Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Aripiprazole/Diazepam/Fluvoxamine/Pitolisant

Various toxicities and pharmacokinetic drug interaction

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is: Drug interaction
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Jiang C, et al. Is pitolisant safe for clinical use? A retrospective pharmacovigilance study focus on the post-marketing safety. Pharmacology Research and Perspectives 12: No. 1, Feb 2024. Available from: URL: https://dx.doi.org/10.1002/prp2.1161 Jiang C, et al. Is pitolisant safe for clinical use? A retrospective pharmacovigilance study focus on the post-marketing safety. Pharmacology Research and Perspectives 12: No. 1, Feb 2024. Available from: URL: https://​dx.​doi.​org/​10.​1002/​prp2.​1161
Metadaten
Titel
Aripiprazole/Diazepam/Fluvoxamine/Pitolisant
Various toxicities and pharmacokinetic drug interaction
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-57207-1

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Linagliptin

Case report

Epoetin-alfa

Case report

Multiple drugs

Case report

Lenalidomide